Nanoparticle-based combination therapy for cancer treatment

Ji Young Yhee, Sejin Son, Hyukjin Lee, Kwang Meyung Kim

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In recent years, combination of different types of therapies using nanoparticles has emerged as an advanced strategy for cancer treatment. Most of all, combination of chemotherapeutic drug and siRNA in nanoformulation has shown a great potential, because siRNA-mediated specific gene silencing can compensate for the incomplete anti-cancer actions of chemotherapy. In this article, nanoparticle-based combination therapy for cancer treatment is introduced to be focused on the therapeutic chemical and siRNA combination. It is classified into 3 groups: 1) general chemotherapy combined with siRNA carrying nanoparticle, 2) co-delivery of chemical and siRNA therapeutics within a single nanoparticle, and 3) Use of multiple nanoparticles for chemical and siRNA therapeutics. The purpose of the combination and the mechanisms of anti-cancer action was described according to the categories. Examples of some recent developments of nanotechnology-based chemo- and siRNA- therapeutics combination therapy are summarized for better understanding of its practical application.

Original languageEnglish
Pages (from-to)3158-3166
Number of pages9
JournalCurrent Pharmaceutical Design
Volume21
Issue number22
DOIs
Publication statusPublished - 2015 Jul 1
Externally publishedYes

Fingerprint

Nanoparticles
Small Interfering RNA
Neoplasms
Therapeutics
Drug Therapy
Nanotechnology
Gene Silencing
Drug Combinations

Keywords

  • Cancer
  • Combination therapy
  • Nanoparticle
  • Targeted drug delivery

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Nanoparticle-based combination therapy for cancer treatment. / Yhee, Ji Young; Son, Sejin; Lee, Hyukjin; Kim, Kwang Meyung.

In: Current Pharmaceutical Design, Vol. 21, No. 22, 01.07.2015, p. 3158-3166.

Research output: Contribution to journalArticle

Yhee, Ji Young ; Son, Sejin ; Lee, Hyukjin ; Kim, Kwang Meyung. / Nanoparticle-based combination therapy for cancer treatment. In: Current Pharmaceutical Design. 2015 ; Vol. 21, No. 22. pp. 3158-3166.
@article{2505401754d64279a4dd301e09437989,
title = "Nanoparticle-based combination therapy for cancer treatment",
abstract = "In recent years, combination of different types of therapies using nanoparticles has emerged as an advanced strategy for cancer treatment. Most of all, combination of chemotherapeutic drug and siRNA in nanoformulation has shown a great potential, because siRNA-mediated specific gene silencing can compensate for the incomplete anti-cancer actions of chemotherapy. In this article, nanoparticle-based combination therapy for cancer treatment is introduced to be focused on the therapeutic chemical and siRNA combination. It is classified into 3 groups: 1) general chemotherapy combined with siRNA carrying nanoparticle, 2) co-delivery of chemical and siRNA therapeutics within a single nanoparticle, and 3) Use of multiple nanoparticles for chemical and siRNA therapeutics. The purpose of the combination and the mechanisms of anti-cancer action was described according to the categories. Examples of some recent developments of nanotechnology-based chemo- and siRNA- therapeutics combination therapy are summarized for better understanding of its practical application.",
keywords = "Cancer, Combination therapy, Nanoparticle, Targeted drug delivery",
author = "Yhee, {Ji Young} and Sejin Son and Hyukjin Lee and Kim, {Kwang Meyung}",
year = "2015",
month = "7",
day = "1",
doi = "10.2174/1381612821666150531165059",
language = "English",
volume = "21",
pages = "3158--3166",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "22",

}

TY - JOUR

T1 - Nanoparticle-based combination therapy for cancer treatment

AU - Yhee, Ji Young

AU - Son, Sejin

AU - Lee, Hyukjin

AU - Kim, Kwang Meyung

PY - 2015/7/1

Y1 - 2015/7/1

N2 - In recent years, combination of different types of therapies using nanoparticles has emerged as an advanced strategy for cancer treatment. Most of all, combination of chemotherapeutic drug and siRNA in nanoformulation has shown a great potential, because siRNA-mediated specific gene silencing can compensate for the incomplete anti-cancer actions of chemotherapy. In this article, nanoparticle-based combination therapy for cancer treatment is introduced to be focused on the therapeutic chemical and siRNA combination. It is classified into 3 groups: 1) general chemotherapy combined with siRNA carrying nanoparticle, 2) co-delivery of chemical and siRNA therapeutics within a single nanoparticle, and 3) Use of multiple nanoparticles for chemical and siRNA therapeutics. The purpose of the combination and the mechanisms of anti-cancer action was described according to the categories. Examples of some recent developments of nanotechnology-based chemo- and siRNA- therapeutics combination therapy are summarized for better understanding of its practical application.

AB - In recent years, combination of different types of therapies using nanoparticles has emerged as an advanced strategy for cancer treatment. Most of all, combination of chemotherapeutic drug and siRNA in nanoformulation has shown a great potential, because siRNA-mediated specific gene silencing can compensate for the incomplete anti-cancer actions of chemotherapy. In this article, nanoparticle-based combination therapy for cancer treatment is introduced to be focused on the therapeutic chemical and siRNA combination. It is classified into 3 groups: 1) general chemotherapy combined with siRNA carrying nanoparticle, 2) co-delivery of chemical and siRNA therapeutics within a single nanoparticle, and 3) Use of multiple nanoparticles for chemical and siRNA therapeutics. The purpose of the combination and the mechanisms of anti-cancer action was described according to the categories. Examples of some recent developments of nanotechnology-based chemo- and siRNA- therapeutics combination therapy are summarized for better understanding of its practical application.

KW - Cancer

KW - Combination therapy

KW - Nanoparticle

KW - Targeted drug delivery

UR - http://www.scopus.com/inward/record.url?scp=84938634622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938634622&partnerID=8YFLogxK

U2 - 10.2174/1381612821666150531165059

DO - 10.2174/1381612821666150531165059

M3 - Article

VL - 21

SP - 3158

EP - 3166

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 22

ER -